Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults (CoronaVac3CL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04651790
Recruitment Status : Recruiting
First Posted : December 3, 2020
Last Update Posted : March 2, 2021
Sponsor:
Collaborators:
Ministry of Health, Chile
Sinovac Biotech Co., Ltd
Information provided by (Responsible Party):
Pontificia Universidad Catolica de Chile

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : March 2022